According to 4basebio's latest financial reports the company's current EPS (TTM) is -$1.28. In 2023 the company made an earnings per share (EPS) of -$1.28 a decrease over its 2022 EPS that were of -$0.83.
Year | EPS | Change |
---|---|---|
2023 | -$1.28 | 55.45% |
2022 | -$0.83 | 44.78% |
2021 | -$0.57 | 341.1% |
2020 | -$0.13 | 76.69% |
2019 | -$0.07322 |